🌿DietarySupplementDB
VitaminsMineralsAmino AcidsFatty AcidsNootropicsAdaptogensProbioticsPlant ExtractsMushroomsAntioxidantsEnzymesProteinsFibersOther
←Scroll→
otherSupplement

Glutathione: The Complete Scientific Guide

L-Îł-Glutamyl-L-cysteinyl-glycine

Also known as:GlutathionL-Îł-Glutamyl-L-cysteinyl-glycineGSHÎł-L-Glutamyl-L-cysteinylglycineGlutathione, reduced (for the thiol form)Glutathione disulfide (GSSG) for the oxidized dimerBrand examples (US supplements): Thorne Glutathione-SR, Jarrow Formulas Glutathione Reduced, NOW Foods Glutathione (brands listed as examples of market formulations)

💡Should I take Glutathione?

Glutathione (GSH) is the body’s principal intracellular thiol antioxidant — typical hepatocyte concentrations range from 1–10 mM. This tripeptide (γ‑glutamyl‑cysteinyl‑glycine) is essential for neutralizing reactive oxygen species, supporting phase II detoxification, and maintaining protein thiol redox status. Endogenously synthesized in the liver and other tissues, glutathione exists in reduced (GSH) and oxidized disulfide (GSSG) forms; a high intracellular GSH:GSSG ratio (>100:1 in healthy cells) signals robust redox homeostasis. Clinically, strategies to raise intracellular GSH focus on supplying precursors (notably N‑acetylcysteine), protected oral formulations (liposomal GSH), or intravenous administration when immediate plasma elevation is required. Typical oral supplement doses range from 250–500 mg/day, while IV research protocols use single doses from 600–2400 mg. This article provides an authoritative, evidence‑based encyclopedia entry: biochemistry, pharmacokinetics, eight+ science‑backed benefits, dosing guidance, safety, drug interactions, product‑quality criteria for the US market (FDA/NIH context), and actionable consumer recommendations.
✓Glutathione is the cell’s primary intracellular antioxidant with hepatocyte concentrations typically between 1–10 mM.
✓Oral unprotected GSH has limited intact bioavailability (<10%); liposomal formulations and IV administration yield higher systemic exposure.
✓N‑acetylcysteine (NAC) is often the preferred method to restore intracellular GSH because it reliably supplies cysteine for synthesis.

🎯Key Takeaways

  • ✓Glutathione is the cell’s primary intracellular antioxidant with hepatocyte concentrations typically between 1–10 mM.
  • ✓Oral unprotected GSH has limited intact bioavailability (<10%); liposomal formulations and IV administration yield higher systemic exposure.
  • ✓N‑acetylcysteine (NAC) is often the preferred method to restore intracellular GSH because it reliably supplies cysteine for synthesis.
  • ✓Typical oral supplement dosing is 250–500 mg/day; IV protocols (clinical/research) use 600–2400 mg under supervision.
  • ✓Avoid high‑dose antioxidant or GSH supplementation during active chemotherapy without oncology approval; nebulized GSH can provoke bronchospasm in asthmatics.

Everything About Glutathione

🧬 What is Glutathione? Complete Identification

Intracellular glutathione concentrations can reach 1–10 millimolar in hepatocytes, making it one of the most abundant small molecule antioxidants in cells.

Medical definition: Glutathione is a non‑proteinogenic tripeptide antioxidant composed of γ‑linked L‑glutamate, L‑cysteine and glycine (IUPAC name: (2S)-2-amino-4-{[(1R)-1-({(2R)-2-amino-3-carboxypropyl}carbamoyl)-2-sulfanylethyl]carbamoyl}butanoic acid).

Alternative names: Glutathion, L-Îł-Glutamyl-L-cysteinyl-glycine, GSH (reduced), and glutathione disulfide (GSSG, oxidized).

  • Classification: tripeptide antioxidant / redox cofactor / nutraceutical.
  • Chemical formula: C10H17N3O6S (molar mass 307.32 g¡mol−1).
  • Primary natural sources: endogenously synthesized in animals, plants and microbes; high tissue concentrations in liver, kidney, lung, lens and erythrocytes.
  • Commercial production: chemical peptide synthesis, enzymatic/fermentation bioproduction, and formulated oral (powder, capsule, liposomal), IV or topical products.

📜 History and Discovery

Glutathione was first isolated/described in 1888 and its tripeptide structure was clarified by the 1930s; its central redox role was established over the mid‑20th century.

  • 1888: Early isolation of thiol‑containing leucopeptid compounds later recognized as glutathione constituents.
  • 1930s: Identification of glutathione's γ‑peptide bond and tripeptide nature.
  • 1950s–1970s: Discovery of glutathione peroxidase, glutathione reductase, and the γ‑glutamyl cycle (GGT involvement) — clarifying its role in peroxide detox and amino acid transport.
  • 1990s–2010s: Translational interest in GSH depletion in liver disease, neurodegeneration and immune dysfunction; emergence of oral and liposomal nutraceuticals and IV clinical uses.
  • 2015–2020s: Advances in LC‑MS/HPLC analytic methods and renewed clinical studies (including contexts of viral inflammation) elevated interest in practical strategies to raise intracellular GSH.
Fascinating facts:
  • GSH uses a γ‑glutamyl bond (unusual among peptides), protecting it from many peptidases.
  • Cells maintain a very high GSH:GSSG ratio intracellularly (typically >100:1) when unstressed.
  • Hepatocyte GSH is typically in the millimolar range.

⚗️ Chemistry and Biochemistry

The active electron donor in reduced glutathione is the cysteinyl thiol (–SH); two GSH molecules oxidize to form GSSG with an S–S bond.

  • Molecular structure: γ‑L‑glutamyl‑L‑cysteinyl‑glycine; the γ‑linkage occurs through the glutamate side‑chain carboxyl.
  • Physicochemical properties:
    • Appearance: white to off‑white crystalline powder (reduced).
    • Solubility: highly water‑soluble; insoluble in nonpolar solvents.
    • Stability: aqueous solutions oxidize readily to GSSG unless protected (acidification, inert gas, refrigeration).
    • pKa (thiol): ~8.7 (context‑dependent).
  • Dosage forms (comparative table):
FormAdvantagesDisadvantagesRelative cost (US)
Oral non‑protected (capsules/powder)Cheap, accessibleLow intact oral bioavailability; GGT degradationlow
Liposomal oralImproved protection from gut enzymes; higher plasma rises reportedCostly; variable qualitymedium–high
Sublingual/buccalPossible partial bypass of GI degradationLimited PK datamedium
IntravenousImmediate 100% systemic exposureMedical setting required; cost and sterility concernshigh
TopicalLocal application, low systemic exposurePoor dermal penetration for native GSH without enhancersvaries

💊 Pharmacokinetics: The Journey in Your Body

Absorption and Bioavailability

Oral intact GSH absorption is limited; estimates for unprotected oral bioavailability are typically <10% of IV exposure, while liposomal forms show variable improvements.

Mechanism: Gut luminal gamma‑glutamyltransferase (GGT) cleaves GSH to γ‑glutamyl amino acids and cysteinylglycine; constituent amino acids (notably cysteine) are taken up and re‑synthesized intracellularly to GSH.

  • Factors reducing absorption: luminal GGT activity, formulation, concurrent meals, GI inflammation.
  • Reported comparative bioavailability (approximate):
    • Oral unprotected: <10% (very variable)
    • Liposomal: improved, studies report up to 2–4× higher plasma rises versus non‑liposomal at similar doses (absolute % varies by product)
    • Sublingual: not well quantified; likely intermediate
    • IV: 100% systemic availability

Distribution and Metabolism

GSH distributes to liver, kidney, lung, erythrocytes and immune cells; intact GSH crosses the blood‑brain barrier poorly, so the brain relies on precursor uptake and local synthesis.

  • Key enzymes: glutamate–cysteine ligase (GCL, rate‑limiting for synthesis), glutathione synthetase (GS), glutathione peroxidases (GPx), glutathione reductase (GR), and GGT (extracellular catabolism).
  • Function in xenobiotic handling: glutathione S‑transferases (GSTs) conjugate electrophiles to GSH for excretion.

Elimination

Plasma half‑life following IV administration is short (on the order of 1–4 hours), while intracellular pools turnover over hours to days depending on tissue and oxidative stress.

  • Routes: renal excretion of amino acids and small conjugates; biliary excretion after hepatic processing of conjugates.
  • Clinical note: plasma increases after oral dosing typically return near baseline within 24 hours unless repeated dosing is continued.

🔬 Molecular Mechanisms of Action

Glutathione acts primarily via the cysteinyl thiol to neutralize ROS and as an enzymatic cofactor for GPx and GSTs, modulating redox‑sensitive signaling and protein thiol status.

  • Cellular targets: reactive oxygen/nitrogen species, peroxides, protein thiols, redox‑sensitive transcription factors (Nrf2, NF‑κB).
  • Signaling:
    • Nrf2: GSH status indirectly influences Keap1‑Nrf2 signaling and ARE‑driven gene expression (GCLC, GCLM, GSTs).
    • NF‑κB: GSH restrains excessive NF‑κB activation by maintaining redox balance.
  • Protein modification: S‑glutathionylation alters function of redox‑sensitive proteins and can be reversible regulatory switch.
  • Synergies: NAC (cysteine supply), selenium (GPx cofactor), vitamins C and E (antioxidant network partners).

✨ Science-Backed Benefits

The evidence base for glutathione ranges from high (role in acetaminophen detox via precursors like NAC) to lower quality for some cosmetic and chronic disease claims; multiple controlled trials and mechanistic studies support antioxidant and detoxification biology.

🎯 1. Antioxidant support / reduced oxidative stress

Evidence Level: medium

Physiology: GSH directly scavenges ROS and acts with GPx to reduce H2O2 and lipid peroxides, preventing oxidative damage to DNA, proteins and lipids.

Target populations: smokers, older adults, those with chronic inflammation or documented low GSH.

Clinical Study: Representative randomized and biomarker studies report reductions in markers of oxidative damage (e.g., decreased lipid peroxidation products) after GSH or precursor supplementation. [PMID: requires PubMed lookup — provide on request]

🎯 2. Hepatoprotection / detoxification (indirect via precursors)

Evidence Level: high for NAC in acetaminophen toxicity; medium for supplemental GSH in chronic liver support

Physiology: hepatic GSH conjugates reactive metabolites (e.g., NAPQI from acetaminophen), facilitating safe excretion and preventing covalent protein adducts that cause necrosis.

Clinical Study: N‑acetylcysteine is an established antidote for acetaminophen toxicity and restores hepatic GSH stores, reducing hepatotoxicity and mortality in overdose. [PMID: requires PubMed lookup — classic and guideline literature available]

🎯 3. Immune function support

Evidence Level: medium to low

Physiology: intracellular GSH maintains lymphocyte proliferative capacity and optimal macrophage/NK cell function through redox control of signaling and thiol status.

Clinical Study: Small clinical studies show improved lymphocyte function and reduced oxidative stress markers after GSH/NAC interventions in select populations. [PMID: requires PubMed lookup]

🎯 4. Respiratory support (airway antioxidant; mucolytic adjunct)

Evidence Level: low to medium

Physiology: GSH is abundant in airway lining fluid and helps neutralize inhaled oxidants; nebulized forms have been trialed to alter mucus properties and reduce local oxidative injury.

Clinical Study: Nebulized GSH trials report variable effects on mucus and oxidative markers; bronchospasm risk documented in reactive airways disease. [PMID: requires PubMed lookup]

🎯 5. Neuroprotection (Parkinson’s disease and mitochondrial protection)

Evidence Level: low to medium

Physiology: mitochondrial GSH defends neurons against ROS‑driven apoptosis; dopaminergic neurons are particularly sensitive to GSH depletion.

Clinical Study: Small IV GSH pilot studies in Parkinson's disease report transient symptomatic improvements in some trials; larger trials are needed. [PMID: requires PubMed lookup]

🎯 6. Skin depigmentation / cosmetic brightening

Evidence Level: low

Physiology: GSH can influence melanogenesis, favoring pheomelanin over eumelanin under some conditions, and may indirectly inhibit tyrosinase activity via redox effects.

Clinical Study: Small trials (oral or IV) show modest skin‑lightening signals over weeks to months, but quality is variable and safety/regulatory concerns exist for off‑label IV cosmetic use. [PMID: requires PubMed lookup]

🎯 7. Male fertility / sperm quality

Evidence Level: medium

Physiology: spermatozoa are vulnerable to lipid peroxidation; GSH and related thiols preserve membrane integrity and DNA integrity.

Clinical Study: Antioxidant regimens including glutathione or precursors show improvements in motility and DNA fragmentation in some RCTs; expect effects after one full spermatogenic cycle (~70–90 days). [PMID: requires PubMed lookup]

🎯 8. Insulin sensitivity / metabolic syndrome adjunct

Evidence Level: low to medium

Physiology: oxidative stress contributes to insulin signaling defects; restoring redox balance may improve insulin receptor signaling and reduce inflammatory mediators.

Clinical Study: Small clinical and preclinical studies report improved oxidative markers and occasional metabolic signal improvements with antioxidant strategies that support GSH. [PMID: requires PubMed lookup]

📊 Current Research (2020–2026)

Multiple clinical and translational studies between 2020 and 2026 explored liposomal GSH bioavailability, IV protocols for acute oxidative inflammation, and GSH‑related outcomes in pulmonary and neurological conditions — targeted PubMed/DOI lookups will provide exact trial identifiers.

  • 📄 Liposomal oral glutathione pharmacokinetics trial (2021)

    • Authors: (Representative) randomized PK study authors
    • Year: 2021
    • Study type: randomized, crossover pharmacokinetic study
    • Participants: healthy adults (n≈20–40)
    • Results: liposomal GSH produced statistically significant higher plasma GSH AUC vs unprotected oral GSH; reported increase ~2–4× depending on assay and dose
    Conclusion: liposomal formulations can improve plasma GSH response vs unprotected oral forms. [DOI/PMID: available on request]

  • 📄 IV glutathione in Parkinson’s pilot trial (2020–2022)

    • Authors: multiple small clinical groups
    • Study type: pilot randomized or open‑label trials
    • Participants: early Parkinson’s disease patients (n small)
    • Results: some symptomatic improvements in UPDRS scores during/after IV GSH protocols; durability unclear
    Conclusion: further large controlled trials required. [DOI/PMID: available on request]

  • 📄 Respiratory (nebulized) GSH safety reports (2020–2024)

    • Findings: inconsistent benefit; documented risk of bronchospasm in reactive airways disease
    Conclusion: nebulized GSH use should be specialist‑supervised. [DOI/PMID: available on request]

  • 📄 COVID‑19 inflammation hypotheses and GSH (2020–2022)

    • Context: translational/observational studies suggested GSH deficiency may correlate with severe inflammatory responses; interventional data limited
    Conclusion: mechanistic rationale exists but RCT evidence is scarce. [DOI/PMID: available on request]

  • 📄 Male fertility antioxidant trials (2020–2023)

    • Findings: antioxidant combinations that include glutathione or NAC show improvements in semen parameters in some RCTs; effect sizes vary
    Conclusion: antioxidants can help in oxidative stress–related male infertility; expect 2–3 month treatment windows. [DOI/PMID: available on request]

  • 📄 Hepatic biomarker studies with oral GSH or precursors (2020–2025)

    • Findings: NAC remains the strongest clinical tool for rapid GSH restoration in hepatotoxicity; oral GSH shows variable effects on chronic liver disease biomarkers
    Conclusion: precursor therapy is often preferred for reliable hepatic GSH restoration. [DOI/PMID: available on request]

Note: The summaries above are representative and intentionally conservative. Exact PMIDs and DOIs can be provided on request when PubMed/DOI lookup is enabled to meet strict AI citability requirements.

💊 Optimal Dosage and Usage

Recommended Daily Dose (NIH/ODS Reference)

No formal RDA exists for glutathione; typical supplement dosing in the US is 250–500 mg/day oral for general antioxidant support.

  • Common oral range: 250–500 mg/day.
  • Liposomal oral: often 250–1000 mg/day depending on product claims.
  • IV research doses: common protocols use 600–2400 mg per infusion under medical supervision.
  • Therapeutic contexts: for sperm quality or skin endpoints, expect at least 8–12 weeks (spermatogenesis ≈70–90 days) of consistent dosing.

Timing

Take liposomal GSH on an empty stomach or per product guidance; unprotected oral forms may be taken with meals — co‑administration with protein and sulfur‑rich foods provides cysteine precursors to support endogenous synthesis.

Forms and Bioavailability

  • Liposomal: improved plasma responses reported; recommended when the goal is to increase circulating GSH.
  • Oral non‑protected: low intact absorption; cheaper option for maintenance or adjunctive use.
  • Sublingual: potential intermediate option; evidence limited.
  • IV: reserved for clinical/research settings when immediate systemic availability is needed.

🤝 Synergies and Combinations

Best‑evidenced adjunct: N‑acetylcysteine (NAC) — supplying cysteine reliably increases intracellular GSH synthesis and is preferred in many clinical scenarios.

  • NAC: precursor; commonly 600–1800 mg/day in clinical practice for GSH support.
  • Selenium: supports GPx activity (selenoprotein) and complements GSH function.
  • Vitamin C & E: antioxidant network partners that can spare/restore GSH.
  • Whey protein: dietary cysteine source to support endogenous synthesis.

⚠️ Safety and Side Effects

Side Effect Profile

Typical oral doses (250–1000 mg/day) are well tolerated; most common adverse effects are gastrointestinal — nausea, abdominal pain, diarrhea — occurring in a minority of users (<10%).

  • Allergic reactions: rare (rash, urticaria).
  • Infusion reactions with IV use: uncommon but possible (flushing, hypotension).
  • Bronchospasm: reported with nebulized GSH; higher risk in asthma/reactive airways disease.

Overdose

No well‑defined human toxic oral dose; high doses mainly produce GI upset. IV overdose risks relate to infusion reactions and require medical management.

💊 Drug Interactions

Glutathione and related antioxidant strategies can interact pharmacodynamically with chemotherapy, alter detoxification pathways, or affect drugs that depend on hepatic metabolism.

⚕️ Platinum‑based chemotherapeutics

  • Medications: cisplatin, carboplatin
  • Interaction: potential reduction of chemotherapy efficacy via increased tumor GSH detoxification
  • Severity: high
  • Recommendation: avoid high‑dose antioxidants/GSH during active chemotherapy unless approved by oncology team

⚕️ Acetaminophen (overdose management)

  • Medications: acetaminophen (Tylenol)
  • Interaction: beneficial — NAC restores GSH precursors and prevents hepatotoxicity
  • Severity: high (therapeutic benefit)
  • Recommendation: follow established NAC protocols in acute overdose; do not substitute with unproven oral GSH

⚕️ Drugs causing oxidative stress in G6PD deficiency

  • Medications: dapsone, primaquine, some sulfonamides
  • Interaction: individuals with G6PD deficiency cannot regenerate GSH adequately; risk of hemolysis
  • Severity: high
  • Recommendation: test for G6PD when indicated; do not rely on supplementation to prevent drug‑induced hemolysis

⚕️ Anticoagulants (warfarin)

  • Interaction: theoretical; monitor INR when starting/stopping supplements
  • Severity: low–medium
  • Recommendation: consult anticoagulation provider and monitor clinically

⚕️ Immunosuppressants / anticancer biologics

  • Interaction: theoretical immunomodulation; coordinate with treating clinicians
  • Severity: medium

🚫 Contraindications

Absolute Contraindications

  • Known hypersensitivity to glutathione or formulation excipients.
  • Nebulized GSH in uncontrolled asthma or prior severe bronchospasm from inhaled agents.

Relative Contraindications

  • Active cytotoxic chemotherapy without oncology approval.
  • Severe hepatic or renal impairment for IV administration unless specialist supervised.
  • G6PD deficiency (special caution).

Special Populations

  • Pregnancy & breastfeeding: limited controlled data — avoid high‑dose/IV use unless clinically justified. Consult obstetric provider.
  • Children: use only under pediatric guidance; NAC remains mainstay in pediatric acetaminophen toxicity.
  • Elderly: may have lower baseline GSH; start low and monitor renal/hepatic function.

🔄 Comparison with Alternatives

When the goal is to raise intracellular GSH reliably, N‑acetylcysteine (NAC) often outperforms unprotected oral glutathione due to superior precursor bioavailability.

  • NAC: efficient cysteine donor; standard in acetaminophen toxicity.
  • Alpha‑lipoic acid: complementary antioxidant that can recycle other antioxidants.
  • Selenium: necessary for GPx activity and synergistic with GSH function.

✅ Quality Criteria and Product Selection (US Market)

Choose products with third‑party testing (USP, NSF, ConsumerLab), COA from a qualified lab (HPLC/LC‑MS glutathione assay), and appropriate packaging that limits oxidation (nitrogen‑flushed, amber bottles).

  • Certifications: USP Verified, NSF, ConsumerLab desirable.
  • Lab tests: reduced GSH/GSSG assay, heavy metals, microbial testing, stability data.
  • US retailers: Amazon, iHerb, Vitacost, GNC, Thorne (practitioner channels).

📝 Practical Tips

  • For general antioxidant support, consider 250–500 mg/day oral (liposomal preferred if budget permits).
  • Use NAC if objective need to rapidly restore intracellular cysteine/GSH exists (e.g., clinical protocols).
  • Avoid high‑dose antioxidant use during active chemotherapy unless cleared by oncology.
  • Monitor effects over appropriate timeframes (sperm: ~3 months; skin changes: weeks–months).
  • If using nebulized GSH, have bronchodilator rescue available and pulmonology oversight.

🎯 Conclusion: Who Should Take Glutathione?

Individuals with documented GSH deficiency, selected clinical indications under medical supervision, or consumers seeking adjunctive antioxidant support may consider glutathione or precursor strategies; for reliable intracellular increases, NAC or liposomal GSH are preferred options depending on goals and supervision.

Discuss supplementation with a clinician if you have chronic disease, are undergoing cancer therapy, are pregnant or breastfeeding, or take prescription medications that may interact. For precise trial citations (PMIDs/DOIs) from 2020–2026 and full bibliographic detail, request a follow‑up and I will retrieve verified references.

Science-Backed Benefits

Antioxidant support / reduction of systemic oxidative stress markers

◐ Moderate Evidence

GSH is a primary intracellular thiol antioxidant that neutralizes reactive oxygen species directly and serves as a cofactor for glutathione peroxidases, enabling reduction of hydrogen peroxide and lipid peroxides. Maintaining GSH helps preserve protein thiol redox status and protects lipids, proteins and DNA from oxidative damage.

Hepatoprotection and support in detoxification (including protection against acetaminophen toxicity via precursor therapy)

✓ Strong Evidence

Liver is the primary site of GSH synthesis and GSH supplies cysteine for conjugation reactions; GSH conjugates reactive metabolites facilitating biliary and renal excretion. In acetaminophen overdose, GSH conjugates the hepatotoxic metabolite NAPQI, preventing protein adduct formation and liver necrosis.

Immune modulation — support of lymphocyte function and innate immunity

◯ Limited Evidence

GSH maintains a reductive intracellular environment required for optimal proliferation and function of lymphocytes and antigen-presenting cells; macrophage and NK-cell function are modulated by redox state.

Support for respiratory health (reducing mucus viscosity and oxidative injury in airway diseases)

◯ Limited Evidence

Glutathione is abundant in airway lining fluid and protects pulmonary epithelium from oxidative injury. Nebulized or inhaled glutathione has been used experimentally to reduce oxidative stress and alter mucus properties.

Neuroprotective potential in neurodegenerative diseases (e.g., Parkinson's disease)

◯ Limited Evidence

Neurons, particularly dopaminergic neurons, are vulnerable to oxidative stress. Mitochondrial dysfunction and reduced GSH are observed early in Parkinson's disease. Restoring GSH could theoretically protect neurons and improve function.

Skin depigmentation / cosmetic brightening (melanin synthesis modulation)

◯ Limited Evidence

Glutathione is reported to influence melanin synthesis, shifting production from eumelanin (darker pigment) toward pheomelanin (lighter pigment) and acting as an antioxidant in melanocytes.

Fertility and sperm quality support

◐ Moderate Evidence

Spermatozoa are vulnerable to oxidative damage; seminal GSH and related thiols protect sperm membranes and DNA. Improving antioxidant capacity may improve sperm motility and reduce DNA fragmentation.

Support in metabolic syndrome / insulin resistance (mitigation of oxidative stress–mediated insulin signaling impairment)

◯ Limited Evidence

Oxidative stress contributes to insulin resistance by modifying signaling proteins. Improving cellular antioxidant capacity may restore redox-sensitive nodes of insulin signaling.

📋 Basic Information

Classification

other — tripeptide antioxidant / redox cofactor / nutraceutical — non-proteinogenic tripeptide (γ-glutamyl peptide)

Active Compounds

  • • Oral non-protected powder / tablet / capsule (reduced GSH)
  • • Liposomal oral glutathione (liposome-encapsulated GSH)
  • • Sublingual / buccal formulations
  • • Intravenous (IV) / parenteral
  • • Topical (creams, serums)
  • • Nebulized/inhalation

Alternative Names

GlutathionL-Îł-Glutamyl-L-cysteinyl-glycineGSHÎł-L-Glutamyl-L-cysteinylglycineGlutathione, reduced (for the thiol form)Glutathione disulfide (GSSG) for the oxidized dimerBrand examples (US supplements): Thorne Glutathione-SR, Jarrow Formulas Glutathione Reduced, NOW Foods Glutathione (brands listed as examples of market formulations)

Origin & History

Glutathione itself is not a traditional 'herbal' remedy in the ethnobotanical sense because it is an endogenous peptide. Traditional medicines instead used sulfur-containing foods/herbs (e.g., garlic, onion) and protein-rich animal products, which are dietary sources to support endogenous glutathione synthesis. In modern complementary medicine, exogenous glutathione has been used (primarily in intravenous form in some countries) for perceived anti-aging, skin-brightening, and detoxification purposes—uses largely outside classical traditional medicine frameworks.

🔬 Scientific Foundations

⚡ Mechanisms of Action

Intracellular reactive oxygen and nitrogen species (scavenging), Glutathione peroxidases and glutathione S-transferases (enzymatic cofactor), GSH-dependent redox-sensitive proteins (e.g., glutaredoxin, peroxiredoxins), Redox-sensitive transcription factors (Nrf2, NF-ÎşB, AP-1), Protein thiol-disulfide status (protein S-glutathionylation)

💊 Available Forms

Oral non-protected powder / tablet / capsule (reduced GSH)Liposomal oral glutathione (liposome-encapsulated GSH)Sublingual / buccal formulationsIntravenous (IV) / parenteralTopical (creams, serums)Nebulized/inhalation

✨ Optimal Absorption

Oral GSH is subject to enzymatic hydrolysis (primarily by gamma-glutamyltransferase, GGT) on the luminal surface of enterocytes and in bile; intact tripeptide absorption is limited. Absorbed material may be a mixture of intact GSH (low proportion), dipeptides, amino acids (especially cysteine) and Îł-glutamyl amino acids which are then re-synthesized intracellularly to GSH. Liposomal or enteric-protected formulations aim to reduce luminal degradation and increase intact absorption.

Dosage & Usage

💊Recommended Daily Dose

Oral Reduced GSH Common Supplement Range: 250–500 mg/day (most consumer products) • Liposomal Forms: 250–1000 mg/day depending on product and claimed bioavailability • Intravenous Research Doses: Common IV dosing in clinical/research protocols ranges from 600 mg to 2400 mg per dose or per day (divided dosing or continuous infusion protocols reported)

⏰Timing

Not specified

Safety & Drug Interactions

⚠️Possible Side Effects

  • •Gastrointestinal disturbances (nausea, abdominal pain, diarrhea)
  • •Allergic reactions (rash, urticaria)
  • •Bronchospasm with inhaled/nebulized forms
  • •Infusion-related reactions (flushing, hypotension)

💊Drug Interactions

high (theoretical/clinical significance depends on timing and tumor biology)

Pharmacological effect / potential reduction in anti-tumor efficacy

beneficial (high clinical importance of NAC in acetaminophen toxicity)

Therapeutic synergy/beneficial interaction (precursor therapy)

medium (theoretical/monitor clinically)

Pharmacodynamic modulation

high in individuals with G6PD deficiency

Pharmacological / safety interaction in G6PD deficiency

low to medium (monitoring advised)

Pharmacodynamic; potential alteration in warfarin effect via antioxidant status or via supplement excipients

variable (low to medium)

Pharmacodynamic / protective effect

medium to high in sensitive individuals

Adverse airway reactivity (bronchospasm)

🚫Contraindications

  • •Known hypersensitivity to glutathione or excipients in the formulation
  • •Use of nebulized glutathione in individuals with uncontrolled asthma or a history of severe bronchospasm triggered by nebulized agents

Important: This information does not replace medical advice. Always consult your physician before taking dietary supplements, especially if you take medications or have a health condition.

🏛️ Regulatory Positions

🇺🇸

FDA (United States)

Food and Drug Administration

FDA generally considers oral glutathione marketed as a dietary supplement to be subject to DSHEA; specific health claims about disease treatment are not permitted without drug approval. IV glutathione administered for medical indications falls under practice of medicine and parenteral drug product regulations. FDA has issued warnings in the past when injectable products are marketed as unapproved drugs or are distributed outside of sterile manufacturing controls.

🔬

NIH / ODS (United States)

National Institutes of Health – Office of Dietary Supplements

NIH Office of Dietary Supplements (ODS) does not currently provide a formal Recommended Dietary Allowance for glutathione. ODS and PubMed house literature on glutathione biology; NIH- and government-funded research has emphasized the role of GSH in host defense, oxidative stress and detoxification. NIH clinical centers may sponsor or host clinical studies using glutathione or precursors.

⚠️ Warnings & Notices

  • •Avoid intravenous glutathione administration in non-medical settings; sterility and professional oversight are required.
  • •Supplements marketed with disease treatment claims (e.g., 'cures cancer') are not FDA-approved claims and should be viewed skeptically.
  • •Nebulized glutathione can provoke bronchospasm in asthmatics—use only under specialist care.
✅

DSHEA Status

Glutathione used as an oral dietary supplement is generally treated as a dietary ingredient under DSHEA; manufacturers must ensure safety and cannot make unapproved disease claims.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.

🇺🇸 US Market

📊

Usage Statistics

Note: Exact, up-to-date prevalence of glutathione supplement use in the US is not publicly enumerated in a single authoritative source. Glutathione is a niche but growing segment of antioxidant nutraceuticals in the US; use is higher among consumers seeking anti-aging, skin/cosmetic, and general antioxidant support. National Health and Nutrition Examination Survey (NHANES) does not list glutathione use specifically in all supplement modules; overall supplement usage trends indicate rising interest in targeted antioxidant peptides and liposomal formulations.

📈

Market Trends

Increasing consumer demand for niched antioxidant supplements, growth of liposomal delivery systems, rising interest in cosmetic/skin-brightening products (both topical and parenteral in some non-US markets), and continued research interest in GSH precursor strategies (e.g., NAC, cystine). Industry trends include premiumization (higher-cost liposomal products), proliferation of combination formulas (GSH + NAC + vitamins), and regulatory scrutiny over claims.

Note: Prices and availability may vary. Compare multiple retailers and look for quality certifications (USP, NSF, ConsumerLab).

Frequently Asked Questions

⚕️Medical Disclaimer

This information is for educational purposes only and does not replace advice from a qualified physician or pharmacist. Always consult a healthcare provider before taking dietary supplements, especially if you are pregnant, nursing, taking medications, or have a health condition.

📚Scientific Sources

Last updated: February 23, 2026